Amy A. Lubik

1.3k total citations · 1 hit paper
15 papers, 969 citations indexed

About

Amy A. Lubik is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Amy A. Lubik has authored 15 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Amy A. Lubik's work include Prostate Cancer Treatment and Research (11 papers), Cancer, Lipids, and Metabolism (7 papers) and Metabolism, Diabetes, and Cancer (4 papers). Amy A. Lubik is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Cancer, Lipids, and Metabolism (7 papers) and Metabolism, Diabetes, and Cancer (4 papers). Amy A. Lubik collaborates with scholars based in Canada, Australia and United States. Amy A. Lubik's co-authors include Colleen C. Nelson, Hans Adomat, Martin Gleave, Stephen C. Hendy, Jennifer A. Locke, Susan Ettinger, Emma S. Tomlinson Guns, Catherine A. Wood, Jennifer H. Gunter and Michaël Pollak and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Amy A. Lubik

15 papers receiving 947 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate Cancer

2008 589 citations Jennifer A. Locke, Emma S. Tomlinson Guns et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy A. Lubik Canada	11	642	381	331	286	166	15	969
Walid J. Azar Australia	11	190 0.3×	480 1.3×	262 0.8×	181 0.6×	63 0.4×	11	827
Xianhui Ruan China	16	138 0.2×	647 1.7×	332 1.0×	147 0.5×	64 0.4×	63	982
LaMonica V. Stewart United States	17	172 0.3×	477 1.3×	207 0.6×	97 0.3×	151 0.9×	28	793
H. Bühler Germany	17	114 0.2×	216 0.6×	74 0.2×	166 0.6×	62 0.4×	42	650
Youngtae Jeong United States	11	154 0.2×	504 1.3×	199 0.6×	50 0.2×	43 0.3×	20	805
G Strada Italy	14	277 0.4×	393 1.0×	145 0.4×	68 0.2×	27 0.2×	25	761
Kazutaka Narimoto Japan	15	259 0.4×	167 0.4×	85 0.3×	74 0.3×	47 0.3×	39	622
Adheesh Bhandari China	18	141 0.2×	514 1.3×	375 1.1×	115 0.4×	22 0.1×	66	819
Shuji Nagasaki Japan	15	184 0.3×	263 0.7×	137 0.4×	100 0.3×	377 2.3×	18	688

Countries citing papers authored by Amy A. Lubik

Since Specialization

Citations

This map shows the geographic impact of Amy A. Lubik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy A. Lubik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy A. Lubik more than expected).

Fields of papers citing papers by Amy A. Lubik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy A. Lubik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy A. Lubik. The network helps show where Amy A. Lubik may publish in the future.

Co-authorship network of co-authors of Amy A. Lubik

This figure shows the co-authorship network connecting the top 25 collaborators of Amy A. Lubik. A scholar is included among the top collaborators of Amy A. Lubik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy A. Lubik. Amy A. Lubik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Nouri, Mannan, Josselin Caradec, Amy A. Lubik, et al.. (2020). Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer. Clinical Cancer Research. 26(7). 1678–1689. 29 indexed citations

Lee, Wendy, Elizabeth D. Williams, Amy A. Lubik, et al.. (2019). Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2. Frontiers in Endocrinology. 10. 481–481. 24 indexed citations

Li, Na, et al.. (2018). Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3. Oncogene. 37(17). 2313–2325. 30 indexed citations

Lubik, Amy A., Mannan Nouri, Mazyar Ghaffari, et al.. (2016). Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironment. International Journal of Cancer. 140(2). 358–369. 30 indexed citations

Sadowski, Martin C., Rebecca H. Pouwer, Jennifer H. Gunter, et al.. (2014). The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer. Oncotarget. 5(19). 9362–9381. 7 indexed citations

Lubik, Amy A., Jennifer H. Gunter, Brett G. Hollier, et al.. (2013). IGF2 increases de novo steroidogenesis in prostate cancer cells. Endocrine Related Cancer. 20(2). 173–186. 42 indexed citations

Gunter, Jennifer H., et al.. (2013). New Players for Advanced Prostate Cancer and the Rationalisation of Insulin-Sensitising Medication. International Journal of Cell Biology. 2013. 1–13. 21 indexed citations

Seim, Inge, Amy A. Lubik, Melanie Lehman, et al.. (2012). Cloning of a novel insulin-regulated ghrelin transcript in prostate cancer. Journal of Molecular Endocrinology. 50(2). 179–191. 18 indexed citations

Gunter, Jennifer H., et al.. (2012). The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer. Advances in Urology. 2012. 1–11. 18 indexed citations

10.

Lubik, Amy A., Jennifer H. Gunter, Stephen C. Hendy, et al.. (2011). Insulin Increases De Novo Steroidogenesis in Prostate Cancer Cells. Cancer Research. 71(17). 5754–5764. 91 indexed citations

11.

Lubik, Amy A., Jennifer H. Gunter, Brett G. Hollier, et al.. (2011). Insulin increases De Novo Steroidogenesis in prostate cancer cells. QUT ePrints (Queensland University of Technology). 3 indexed citations

12.

Sieh, Shirly, Amy A. Lubik, Judith A. Clements, Colleen C. Nelson, & Dietmar W. Hutmacher. (2010). Interactions between human osteoblasts and prostate cancer cells in a novel 3D in vitro model. Organogenesis. 6(3). 181–188. 64 indexed citations

13.

Locke, Jennifer A., Emma S. Tomlinson Guns, Melanie Lehman, et al.. (2009). Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistance. The Prostate. 70(3). 239–251. 1 indexed citations

14.

Locke, Jennifer A., Ladan Fazli, Hans Adomat, et al.. (2009). A novel communication role for CYP17A1 in the progression of castration‐resistant prostate cancer. The Prostate. 69(9). 928–937. 2 indexed citations

15.

Locke, Jennifer A., Emma S. Tomlinson Guns, Amy A. Lubik, et al.. (2008). Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate Cancer. Cancer Research. 68(15). 6407–6415. 589 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact